Clinical laboratory. Absence of apolipoprotein B-100. Lp (a) lipoprotein as an acute phase reactant
Kawade, M.
Rinsho Byori. Japanese Journal of Clinical Pathology 34(4): 419-422
1986
ISSN/ISBN: 0047-1860 PMID: 2943917 Document Number: 280630
Document emailed within 1 workday
Related Documents
Weber, M.; McNicoll, S.; Marcil, M.; Connelly, P.; Lussier-Cacan, S.; Davignon, J.; Latour, Y.; Genest, J. 1997: Metabolic factors clustering, lipoprotein cholesterol, apolipoprotein B, lipoprotein (a) and apolipoprotein E phenotypes in premature coronary artery disease in French Canadians Canadian Journal of Cardiology 13(3): 253-260Schutte, M.; DiCamelli, R.; Murphy, P.; Sadove, M.; Gewurz, H. 1974: C3 proactivator (C3PA) as an acute phase reactant Clinical and Experimental Immunology 18(2): 251-256
San Miguel, J.; Corrales, A.; Alberca, I.; Vicente, V.; Lopez Borrasca, A. 1983: Acute phase reactant proteins in differential diagnosis of monoclonal gammopathy Neoplasma 30(1): 57-62
Viganò, S.; Mannucci, P.M.; D'Angelo, A.; Gelfi, C.; Gensini, G.F.; Rostagno, C.; Neri Serneri, G.G. 1984: Protein C antigen is not an acute phase reactant and is often high in ischemic heart disease and diabetes Thrombosis and Haemostasis 52(3): 263-266
Kuvibidila, S.; Warrier, R.P.; Yu, L.; Ode, D.; Mbele, V. 1994: Reference levels of acute phase reactant proteins in healthy Zairean women in the reproductive age group Journal of Tropical Medicine and Hygiene 97(4): 239-243
Pratap, V.K.; Singh, S.; Singh, S.N.; Saxena, H.; Nath, K. 1974: Acute phase "reactant" tests in congestive cardiac failure to assess the presence of fresh rheumatic activity Journal of the Association of Physicians of India 22(2): 143-151
Yildirim, K.; Karatay, S.; Melikoglu, M.Alkan.; Gureser, G.; Ugur, M.; Senel, K. 2005: Associations between acute phase reactant levels and disease activity score (DAS28) in patients with rheumatoid arthritis Annals of Clinical and Laboratory Science 34(4): 423-426
Song, W.; Chen, J.; Redinger, R.N. 1998: Apolipoprotein A-I complexed with phospholipid promotes hepatic lipoprotein and apolipoprotein secretion in the perfused hamster liver Journal of Investigative Medicine: the Official Publication of the American Federation for Clinical Research 46(9): 460-469
Huang, T.G. 1989: Lipoprotein and apolipoprotein AI, B levels in the blood of male survivors of acute myocardial infarction Zhonghua Xin Xue Guan Bing Za Zhi 17(3): 149-152
Fruchart, J.C.; Ailhaud, G. 1992: Apolipoprotein A-containing lipoprotein particles: physiological role, quantification, and clinical significance Clinical Chemistry 38(6): 793-797
Jovanović, D.; Colić, M.; Joković, B.; Skatarić, V. 1995: The correlation of clinical and laboratory parameters of the acute phase with the evolution of poststreptococcal glomerulonephritis in adults Vojnosanitetski Pregled 52(4): 325-333
Nomura, M.; Suzumura, A.; Anno, H.; Miyata, E.; Koga, S.; Yamamoto, H. 1995: Clinical usefulness of MRi in acute phase of spinal multiple sclerosis--influence of high-dose steroid therapy in acute phase Rinsho Shinkeigaku 35(3): 225-230
Shiokawa, Y. 1987: Clinical study of the acute phase reaction. Acute phase proteins and a chronic inflammation, rheumatoid arthritis Nihon Rinsho. Japanese Journal of Clinical Medicine 45(5): 1068-1075
Hoque, M.M.; Sultana, P.; Arslan, M.I. 2005: Lipoprotein-a: a laboratory tool for clinical categorization of CVD Mymensingh Medical Journal: Mmj 14(1): 75-79
Sathavarodom, N.; Boonyavarakul, A. 2010: Apolipoprotein B level in patients with type 2 diabetes who achieved goal of low density lipoprotein cholesterol and non-high density lipoprotein cholesterol Journal of the Medical Association of Thailand 93(Suppl 6): S166-S172
Rotberg, T.; Nadal Ginard, B.; Zorrilla, E.; Contreras, R. 1971: Nodular diabetic glomerulosclerosis in the absence of clinical ophthalmologic and laboratory data. Presentation of a case Archivos del Instituto de Cardiologia de Mexico 41(1): 106-114
Fruchart, J.C.; Duriez, P. 1995: The important role of apolipoprotein C-IIi in lipoprotein metabolism Comptes Rendus des Seances de la Societe de Biologie et de ses Filiales 189(5): 889-897
Broutin, H.; Puchois, P.; Ailhaud, G.; Barbaras, R.; Torpier, G.; Fruchart, J.C. 1988: Receptors and molecular heterogeneity of lipoprotein particles containing apolipoprotein A-I Annales de Biologie Clinique 46(1): 16-23
Nakao, Y.; Kajikawa, T.; Kushiro, H.; Kodama, J.; Nambu, S.; Yamamura, T.; Yamamoto, A. 1983: Iso-electric focusing method for the analysis of apolipoprotein e in very-low-density lipoprotein Rinsho Byori. Japanese Journal of Clinical Pathology 31(2): 165-173
Kim, S.B.; Yang, W.S.; Kang, E.S.; Min, W.K.; Park, J.S. 1997: Lipoprotein(a) and apolipoprotein(a) phenotypes in patients with end-stage renal disease Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis 17(3): 236-242